Lakefront Biotherapeutics NV (GLPG)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
No upcoming catalysts detected for this company.
Active Clinical Trials (4)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT04985435 | Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH) | PHASE4 | Recruiting | 100 |
| NCT05456412 | JAK Inhibition in Ulcerative Colitis | OTHER | Recruiting | 60 |
| NCT05697159 | 7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis | OTHER | Recruiting | 20 |
| NCT06652633 | Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies | PHASE3 | Recruiting | 546 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.